approval
saveLOSARTAN POTASSIUM — FDA approval
December 16, 2025updated 6mo ago
community read0 votes
Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
same company · ±60 days · 6
- approvalLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalDec 16, 2025
- approvalTRAVOPROST: TRAVOPROST — FDA approvalDec 17, 2025
- approvalloteprednol etabonate: LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE) — FDA approvalDec 10, 2025
- recallAlembic Pharmaceuticals Limited recall (Cls III)Nov 26, 2025
- approvalropinirole hydrochloride ER: ROPINIROLE HYDROCHLORIDE — FDA approvalNov 19, 2025
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJan 14, 2026
🐶 often sniffed alongside
top 8- tagRecall15 co-mentions · 5 sources
- drugElyxyb6 co-mentions · 1 sources
- drugCELECOXIB6 co-mentions · 1 sources
- drugcelecoxib SR6 co-mentions · 1 sources
- drugCelebrex6 co-mentions · 1 sources
- drugfesoterodine fumarate ER6 co-mentions · 2 sources
- drugtadalafil3 co-mentions · 1 sources
- drugdoxepin hydrochloride3 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that